You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (20)

Journals (0)

1-10 of 20 results for oxaliplatin plus fluorouracil and leucovorin

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Leucovorin,Fluorouracil,and Oxaliplatin (FOLFOX) Regimens plus Bevacizumab for Colorectal Cancer

Retricted access

Research article

First published 2010-9

Leucovorin,Fluorouracil,and Oxaliplatin (FOLFOX) Regimens plus Bevacizumab for Colorectal Cancer

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Select article: A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab -Paclitaxel,Bevacizumab,Leucovorin,and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer

Open access

Research article

First published 2019-09

A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab -Paclitaxel,Bevacizumab,Leucovorin,and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer

Vaibhav Sahai, M. Wasif Saif, Aparna Kalyan [...]

Journal of Pancreatic Cancer

Select article: Oxaliplatin in Hepatic Arterial Infusion (Hai) and Systemic Chemotherapy with Leucovorin plus 5-fluorouracil in Metastatic Colorectal Cancer Preliminary Data of a Multicenter Study

Retricted access

Research article

First published 2002-7

Oxaliplatin in Hepatic Arterial Infusion (Hai) and Systemic Chemotherapy with Leucovorin plus 5-fluorouracil in Metastatic Colorectal Cancer Preliminary Data of a Multicenter Study

S Perrone, E Bobbio Pallavicini, F Tacconi [...]

Tumori Journal

Select article: Hepatic Arterial Infusion of Oxaliplatin,Fluorouracil,and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

Open access

Research article

First published 2022

Hepatic Arterial Infusion of Oxaliplatin,Fluorouracil,and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

YeXing Huang, LiHong Zhang, MinKe He [...]

Technology in Cancer Research & Treatment

Select article: Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report

Retricted access

Case report

First published 2018-10

Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report

Satoru Mitsuboshi, Hiromi Kozakai, Hitoshi Yamada [...]

Journal of Oncology Pharmacy Practice

Select article: Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage

Retricted access

Case report

First published 2021-3

Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage

Jasmine Giani, Michael B Sawyer, Carole Chambers

Journal of Oncology Pharmacy Practice

Select article: Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer

Open access

Research article

First published 2021

Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer

Shan Xu, Ali Sak, Yasin Bahadir Erol

Cancer Control

Select article: A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Open access

Research article

First published 2019

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Markus Kieler, Matthias Unseld, Daniela Bianconi [...]

Therapeutic Advances in Medical Oncology

Select article: Assessment of exposure risk of irinotecan and its active metabolite,SN-38,through perspiration during chemotherapy

Retricted access

Research article

First published 2019-6

Assessment of exposure risk of irinotecan and its active metabolite,SN-38,through perspiration during chemotherapy

Kei Irie, Akira Okada, Yoshio Masuda [...]

Journal of Oncology Pharmacy Practice

Select article: Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear

Open access

Review article

First published 2024

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear

Davide Melisi, Simona Casalino, Silvia Pietrobono [...]

Therapeutic Advances in Medical Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access